[A tumor stem cell-specific marker identified by lineage tracing in the intestine]

Area of Science:

• Oncology
• Stem Cell Biology
• Gastroenterology

Context:

• Targeting tumor stem cells (TSCs) is a promising cancer therapy strategy.
• Existing TSC therapies are limited by shared markers between TSCs and normal stem cells (NSCs).
• This overlap can lead to severe damage to normal tissues during treatment.

Purpose:

• To identify a specific marker for intestinal TSCs that differentiates them from NSCs.
• To evaluate the therapeutic potential of targeting this specific marker in intestinal tumors.

Summary:

• Researchers investigated doublecortin-like kinase 1 (Dclk1) as a potential TSC marker.
• In mouse models, Dclk1-positive cells were found to be enriched in intestinal tumors but not normal intestinal epithelium.
• Selective ablation of Dclk1-positive cells led to tumor regression without apparent harm to normal tissues.

Impact:

• Doublecortin-like kinase 1 (Dclk1) serves as a discriminant marker for intestinal TSCs.
• This finding offers a potential strategy for developing targeted therapies against intestinal tumors.
• Targeting Dclk1 may allow for effective tumor eradication with reduced side effects on normal tissues.